Cargando…

Alternative Antibiotics in Dentistry: Antimicrobial Peptides

The rise of antibiotic resistant bacteria due to overuse and misuse of antibiotics in medicine and dentistry is a growing concern. New approaches are needed to combat antibiotic resistant (AR) bacterial infections. There are a number of methods available and in development to address AR infections....

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, Alexandra, Mateen, Akilah, Markowitz, Kenneth, Singer, Steven R., Cugini, Carla, Shimizu, Emi, Wiedman, Gregory R., Kumar, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412702/
https://www.ncbi.nlm.nih.gov/pubmed/36015305
http://dx.doi.org/10.3390/pharmaceutics14081679
_version_ 1784775559289503744
author Griffith, Alexandra
Mateen, Akilah
Markowitz, Kenneth
Singer, Steven R.
Cugini, Carla
Shimizu, Emi
Wiedman, Gregory R.
Kumar, Vivek
author_facet Griffith, Alexandra
Mateen, Akilah
Markowitz, Kenneth
Singer, Steven R.
Cugini, Carla
Shimizu, Emi
Wiedman, Gregory R.
Kumar, Vivek
author_sort Griffith, Alexandra
collection PubMed
description The rise of antibiotic resistant bacteria due to overuse and misuse of antibiotics in medicine and dentistry is a growing concern. New approaches are needed to combat antibiotic resistant (AR) bacterial infections. There are a number of methods available and in development to address AR infections. Dentists conventionally use chemicals such as chlorohexidine and calcium hydroxide to kill oral bacteria, with many groups recently developing more biocompatible antimicrobial peptides (AMPs) for use in the oral cavity. AMPs are promising candidates in the treatment of (oral) infections. Also known as host defense peptides, AMPs have been isolated from animals across all kingdoms of life and play an integral role in the innate immunity of both prokaryotic and eukaryotic organisms by responding to pathogens. Despite progress over the last four decades, there are only a few AMPs approved for clinical use. This review summarizes an Introduction to Oral Microbiome and Oral Infections, Traditional Antibiotics and Alternatives & Antimicrobial Peptides. There is a focus on cationic AMP characteristics and mechanisms of actions, and an overview of animal-derived natural and synthetic AMPs, as well as observed microbial resistance.
format Online
Article
Text
id pubmed-9412702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94127022022-08-27 Alternative Antibiotics in Dentistry: Antimicrobial Peptides Griffith, Alexandra Mateen, Akilah Markowitz, Kenneth Singer, Steven R. Cugini, Carla Shimizu, Emi Wiedman, Gregory R. Kumar, Vivek Pharmaceutics Review The rise of antibiotic resistant bacteria due to overuse and misuse of antibiotics in medicine and dentistry is a growing concern. New approaches are needed to combat antibiotic resistant (AR) bacterial infections. There are a number of methods available and in development to address AR infections. Dentists conventionally use chemicals such as chlorohexidine and calcium hydroxide to kill oral bacteria, with many groups recently developing more biocompatible antimicrobial peptides (AMPs) for use in the oral cavity. AMPs are promising candidates in the treatment of (oral) infections. Also known as host defense peptides, AMPs have been isolated from animals across all kingdoms of life and play an integral role in the innate immunity of both prokaryotic and eukaryotic organisms by responding to pathogens. Despite progress over the last four decades, there are only a few AMPs approved for clinical use. This review summarizes an Introduction to Oral Microbiome and Oral Infections, Traditional Antibiotics and Alternatives & Antimicrobial Peptides. There is a focus on cationic AMP characteristics and mechanisms of actions, and an overview of animal-derived natural and synthetic AMPs, as well as observed microbial resistance. MDPI 2022-08-12 /pmc/articles/PMC9412702/ /pubmed/36015305 http://dx.doi.org/10.3390/pharmaceutics14081679 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Griffith, Alexandra
Mateen, Akilah
Markowitz, Kenneth
Singer, Steven R.
Cugini, Carla
Shimizu, Emi
Wiedman, Gregory R.
Kumar, Vivek
Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title_full Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title_fullStr Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title_full_unstemmed Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title_short Alternative Antibiotics in Dentistry: Antimicrobial Peptides
title_sort alternative antibiotics in dentistry: antimicrobial peptides
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412702/
https://www.ncbi.nlm.nih.gov/pubmed/36015305
http://dx.doi.org/10.3390/pharmaceutics14081679
work_keys_str_mv AT griffithalexandra alternativeantibioticsindentistryantimicrobialpeptides
AT mateenakilah alternativeantibioticsindentistryantimicrobialpeptides
AT markowitzkenneth alternativeantibioticsindentistryantimicrobialpeptides
AT singerstevenr alternativeantibioticsindentistryantimicrobialpeptides
AT cuginicarla alternativeantibioticsindentistryantimicrobialpeptides
AT shimizuemi alternativeantibioticsindentistryantimicrobialpeptides
AT wiedmangregoryr alternativeantibioticsindentistryantimicrobialpeptides
AT kumarvivek alternativeantibioticsindentistryantimicrobialpeptides